MyAverix Finance
US · Healthcare
Eikon Therapeutics, Inc. Common Stock (EIKN)
Biotechnology
Eikon Therapeutics, Inc. Common Stock (EIKN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for EIKN
Eikon Therapeutics, Inc. Common Stock (EIKN) — FAQ
What is EIKN's P/E ratio?
The price-to-earnings (P/E) ratio for Eikon Therapeutics, Inc. Common Stock (EIKN) is 18.00 (data as of 2026-03-24).
Does Eikon Therapeutics, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Eikon Therapeutics, Inc. Common Stock (EIKN). Check the MyAverix Finance app for the latest dividend data.
What sector is Eikon Therapeutics, Inc. Common Stock in?
Eikon Therapeutics, Inc. Common Stock (EIKN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is EIKN listed on?
EIKN is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.